Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Sep-Oct;19(5):602-607.
doi: 10.4103/1008-682X.184269.

Exercise improves the effects of testosterone replacement therapy and the durability of response after cessation of treatment: a pilot randomized controlled trial

Affiliations
Randomized Controlled Trial

Exercise improves the effects of testosterone replacement therapy and the durability of response after cessation of treatment: a pilot randomized controlled trial

Dae-Yeon Cho et al. Asian J Androl. 2017 Sep-Oct.

Abstract

The effects of the combination of exercise and TRT on symptoms of late-onset hypogonadism (LOH) and the durability of response after cessation of TRT were investigated. A total of fifty patients with erectile dysfunction (ED) who had a sedentary lifestyle and low serum total testosterone (T) levels were enrolled and followed for 20 weeks. Patients were randomly divided into two groups; all of them received T gel for 12 weeks and it was discontinued for 8 weeks. Patients assigned to Group II were offered a supervised exercise program for 20 weeks. Measurement of serological testing was performed and self-assessment questionnaires and Global Assessment Question (GAQ) were asked. Baseline characteristics and the initial symptom scores showed no significant difference between the two groups. Serum total T levels and the symptom scores were increased at 12 weeks in both groups, and Group II showed better results with statistical significance. There was a decrease in T levels and worsening of symptom scores at week 20 compared to week 12 in both groups, and Group II showed better results with statistical significance. On the GAQ, Group II showed higher ratio of "yes" at week 12 and the same tendency was sustained at week 20 with significant difference between two groups. The combination of exercise and TRT showed significant improvements in serum T levels and LOH symptoms compared to TRT alone. In addition, these improvements were maintained in the combination group with continuous exercise, even after cessation of TRT.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes of serum total testosterone levels and comparison between two groups (P value by independent t-test, P = 0.019 at 12 weeks, P < 0.001 at 20 weeks). ¥¥P < 0.001 by paired t-test compared to 3 months in Group I, *P < 0.01 by paired t-test compared to 3 months in Group II.
Figure 2
Figure 2
Changes of total score of IIEF and comparison between two groups (P value by independent t-test, P = 0.028 at 12 weeks, P = 0.001 at 20 weeks). ¥¥P < 0.001 by paired t-test compared to 3 months in Group I, *P < 0.01 by paired t-test compared to 3 months in Group II.
Figure 3
Figure 3
Changes of total score of AMS and comparison between two groups (P value by independent t-test, P = 0.045 at 12 weeks, P = 0.007 at 20 weeks). ¥P < 0.01 by paired t-test compared to 3 months in Group I, *P < 0.01 by paired t-test compared to 3 months in Group II.

References

    1. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol. 2008;159:507–14. - PMC - PubMed
    1. Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, et al. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev. 2005;14:2257–60. - PubMed
    1. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536–59. - PubMed
    1. Tsujimura A, Takada S, Matsuoka Y, Hirai T, Takao T, et al. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism? Int J Urol. 2008;15:625–9. - PubMed
    1. O’Connell MD, Roberts SA, Srinivas-Shankar U, Tajar A, Connolly MJ, et al. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men? J Clin Endocrinol Metab. 2011;96:454–8. - PubMed

Publication types